From: Clinical response to varying pollen exposure in allergic rhinitis in children in The Netherlands
2013 (n = 51) | 2014 (n = 99) | P-value | |
---|---|---|---|
Sex (boys), N (%) | 24 (47.1) | 54 (54.5) | 0.385 |
Age (years), mean (SD) | 11.85 (0.54) | 11.57 (0.31) | 0.634 |
Asthma, N (%) | 8 (15.7) | 15 (15.1) | 0.931 |
Grass sensitisation, N (%) | 51 (100) | 99 (100) | 0.471 |
Birch sensitisation, N (%) | 29 (56.9) | 60 (60.6) | 0.658 |
HDM sensitisation, N (%) | 26 (51.0) | 49 (49.5) | 0.863 |
Monosensitisation, N (%) | 11 (21.6) | 24 (24.2) | 0.712 |
Current use of secondary care for AR, N (%) | 2 (3.9) | 12 (12.1) | 0.127 |
Grass sensitisation class > 2, N (%) | 38 (74.5) | 59 (59.6) | 0.043 |
Birch sensitisation class > 2, N (%) | 29 (56.9) | 62 (62.7) | 0.367 |
Retrospective symptom score, mean (SD) | 12.31 (3.10) | 11.93 (3.18) | 0.477 |
Baseline symptom score | 11.47 (4.10) | 10.34 (4.30) | 0.319 |